Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and regeneration
Xiao Zhang, … , Ivaylo I. Ivanov, Nan Gao
Xiao Zhang, … , Ivaylo I. Ivanov, Nan Gao
Published July 20, 2020
Citation Information: JCI Insight. 2020;5(16):e135923. https://doi.org/10.1172/jci.insight.135923.
View: Text | PDF
Research Article Gastroenterology Stem cells

Elevating EGFR-MAPK program by a nonconventional Cdc42 enhances intestinal epithelial survival and regeneration

  • Text
  • PDF
Abstract

The regulatory mechanisms enabling the intestinal epithelium to maintain a high degree of regenerative capacity during mucosal injury remain unclear. Ex vivo survival and clonogenicity of intestinal stem cells (ISCs) strictly required growth response mediated by cell division control 42 (Cdc42) and Cdc42-deficient enteroids to undergo rapid apoptosis. Mechanistically, Cdc42 engaging with EGFR was required for EGF-stimulated, receptor-mediated endocytosis and sufficient to promote MAPK signaling. Proteomics and kinase analysis revealed that a physiologically, but nonconventionally, spliced Cdc42 variant 2 (V2) exhibited stronger MAPK-activating capability. Human CDC42-V2 is transcriptionally elevated in some colon tumor tissues. Accordingly, mice engineered to overexpress Cdc42-V2 in intestinal epithelium showed elevated MAPK signaling, enhanced regeneration, and reduced mucosal damage in response to irradiation. Overproducing Cdc42-V2 specifically in mouse ISCs enhanced intestinal regeneration following injury. Thus, the intrinsic Cdc42-MAPK program is required for intestinal epithelial regeneration, and elevating this signaling cascade is capable of initiating protection from genotoxic injury.

Authors

Xiao Zhang, Sheila Bandyopadhyay, Leandro Pires Araujo, Kevin Tong, Juan Flores, Daniel Laubitz, Yanlin Zhao, George Yap, Jingren Wang, Qingze Zou, Ronaldo Ferraris, Lanjing Zhang, Wenwei Hu, Edward M. Bonder, Pawel R. Kiela, Robert Coffey, Michael P. Verzi, Ivaylo I. Ivanov, Nan Gao

×

Figure 2

Cdc42 is indispensable for EGFR endocytosis.

Options: View larger image (or click on image) Download as PowerPoint
Cdc42 is indispensable for EGFR endocytosis.
(A) WT and Cdc42iKO enteroi...
(A) WT and Cdc42iKO enteroids were treated with 4-OHT for 48 hours. Enteroid sections were stained for endogenous EGFR (green) and mitosis marker (pHH3, red). (B) Quantification of intracellular localization of EGFR in WT and Cdc42iKO enteroid cells, based on immunofluorescence staining of EGFR in 4-OHT–treated enteroids (48 hours). (C) pHH3+ cell number was quantified per enteroid. Data in B and C were quantified from 2 independent experiments. (D) Enteroid sections were stained for EGFR after 4-OHT treatment at 8, 24, and 40 hours. White arrows point to delocalized EGFR compared with EGFR localization in untreated enteroids. (E) Quantification of percentage of cells showing changed EGFR localization at indicated time points after 4-OHT addition. (F) Cdc42 mice were crossed to emEGFR mice to visualize EGFR. Thirty minutes after EGF injection, emEGFR vesicles (green, white arrows) were seen in Cdc42-WT mouse crypt cells but were barely detected in iKO crypt cells. White dotted circles indicate crypt base stem cells. (G and H) Double fluorescence analysis for EEA1 (red) and emEGFR (green, white arrows) detected endocytic EGFR in WT crypt cells but not Cdc42iKO cells 30 minutes after EGF injection. EEA1+EGFR+ puncta per crypt were quantified from 4 mice in 2 independent experiments. (I and J) Western blots for endogenous p-ErbB1 (Y1068), p-ErbB2 (Y1221/1222), and p-Erk1/2 were performed for WT, Cdc42-KO, and Cdc42 V2Tg mouse intestines. Data represent 2 independent experiments. Please also see Supplemental Figure 2.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts